Financial News · Live Terminal

Page 268 of 356

RTX's Raytheon Delivers Second Satellite Sensor to Lockheed Martin Under US Space Force Program

RTX-owned (RTX) Raytheon said Tuesday it has delivered its second sensor to Lockheed Martin (LMT) for the US Space Force's satellite program.The satellites, which are part of the Next-Generation Overhead Persistent Infrared Geosynchronous Earth Orbit Block 0 satellite program, will provide enhanced missile warning and tracking to deal with space-based threats, Raytheon said.Financial terms of the contract were not disclosed.Price: $173.20, Change: $-0.18, Percent Change: -0.10%

$LMT$RTX

Wire61d ago

Market Chatter: Disney TV Licenses May Be Reviewed by FCC

Walt Disney's (DIS) broadcast licenses are moving toward a review by the Federal Communications Commission, Semafor reported Tuesday, citing people familiar with the matter.The FCC may choose not to trigger the early license review process, the sources said, but its chairman Brendan Carr has threatened Disney's licenses as recently as this month over diversity issues, according to the report.Disney and the FCC didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $101.27, Change: $-1.08, Percent Change: -1.06%

$DIS

Wire61d ago

Solid Biosciences Says SGT-003 Gets EU Orphan Drug Designation for Duchenne Muscular Dystrophy

Solid Biosciences (SLDB) said Tuesday the European Commission has granted orphan drug designation to its investigational therapy SGT-003 for Duchenne muscular dystrophy.This decision followed a positive recommendation from the European Medicines Agency's Committee for Orphan Medicinal Products, the company said.SGT-003 already has been granted fast track, orphan drug, and rare pediatric disease designations by the US Food and Drug Administration, the company said, adding that the therapy is currently being tested in two clinical trials aimed at supporting regulatory approval in different countries.Price: $7.54, Change: $+0.04, Percent Change: +0.47%

$SLDB

Wire61d ago

Pfizer Reaches Three Settlements in Vyndamax Patent Infringement Suits

$PFE

Wire61d ago

Protagonist Therapeutics Opts Out of Rusfertide US Profit-Sharing Arrangement With Takeda Pharmaceutical

Protagonist Therapeutics (PTGX) exercised its right to opt out of the 50/50 US profit and loss sharing arrangement under its global license and collaboration agreement with Takeda Pharmaceutical (TAK) for rusfertide, Protagonist Therapeutics said Tuesday.As a result, Protagonist Therapeutics will be eligible to receive up to $400 million in opt-out payments.The company will also be entitled to a $75 million milestone payment upon rusfertide's approval in the US and up to $975 million in other milestone payments and tiered royalties on net sales, according to the statement.Takeda Pharmaceutical now holds exclusive development and commercialization rights to rusfertide in the US.Rusfertide is under FDA Priority Review in the US for the treatment of adult patients with polycythemia vera, Protagonist Therapeutics said.Price: $99.31, Change: $+0.84, Percent Change: +0.85%

$PTGX$TAK

Wire61d ago

Morgan Stanley Trims Price Target on U.S. Bancorp to $64 From $65, Maintains Equalweight Rating

U.S. Bancorp (USB) has an average rating of overweight and mean price target of $62.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $56.37, Change: $+0.40, Percent Change: +0.71%

$USB

Wire61d ago

Infleqtion Wins $1 Million US Navy Contract

Infleqtion (INFQ) said Tuesday that it has received a $1 million US Navy contract to support its Quantum-Inspired Rapid Context machine learning software platform for radio frequency signal processing.The company said the program will support the development of advanced radio-frequency signal-processing capabilities, enhancing situational awareness in complex environments.Infleqtion shares were down over 4% in Tuesday trading.Price: $12.58, Change: $-0.72, Percent Change: -5.41%

$INFQ

Wire61d ago

Dynatrace Shareholder Starboard Discloses Substantial Investment, Urges Constructive Engagement

Dynatrace (DT) was delivered a letter outlining operational strategies to accelerate revenue growth and profitability, Starboard Value said Tuesday.Starboard has made a substantial investment in Dynatrace, according to the letter.The shares currently trade at a severe valuation discount compared to infrastructure peers despite a durable product platform, Starboard added.Dynatrace has an opportunity for value creation, Starboard said, adding that it looks forward to a continued constructive engagement the company's management and the board regarding the goal.Dynatrace didn't immediately reply to request for comment from.Shares of Dynatrace were up 3.2% in Tuesday trading.Price: $36.73, Change: $+1.12, Percent Change: +3.13%

$DT

Wire61d ago

SIM Acquisition Executes LOI With American Industrial for Business Combination

SIM Acquisition Corp. I (SIMA) said Tuesday it has executed a non-binding letter of intent with American Industrial Technologies for a proposed deSPAC business combination.Among other segments, American Industrial Technologies will operate Q1, a fully integrated platform spanning manufacturing, logistics, distribution, and connected device ecosystems.The parties agreed to a 45-day exclusivity period to conduct due diligence and negotiate a definitive business combination agreement, according to the company.Price: $10.78, Change: $+0.01, Percent Change: +0.09%

$SIMA

Wire61d ago

Morgan Stanley Adjusts Price Target on CF Industries to $135 From $95, Maintains Equalweight Rating

CF Industries (CF) has an average rating of hold and mean price target of $122.06, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $123.37, Change: $-0.26, Percent Change: -0.21%

$CF

Wire61d ago

Morgan Stanley Adjusts Targa Resources Price Target to $327 From $298, Maintains Overweight Rating

Targa Resources (TRGP) has an average rating of overweight and mean price target of $264.95, according to analysts polled by FactSet.Price: $245.31, Change: $+4.02, Percent Change: +1.67%

$TRGP

Wire61d ago

Morgan Stanley Adjusts Gilead Sciences Price Target to $175 From $171, Maintains Overweight Rating

Gilead Sciences (GILD) has an average rating of overweight and mean price target of $161, according to analysts polled by FactSet.Price: $128.85, Change: $+1.10, Percent Change: +0.86%

$GILD

Wire61d ago

Morgan Stanley Adjusts Sempra Price Target to $104 From $105, Maintains Overweight Rating

$SRE

Wire61d ago

Morgan Stanley Adjusts Applied Materials Price Target to $432 From $420, Maintains Overweight Rating

$AMAT

Wire61d ago

Morgan Stanley Adjusts Price Target on Valero Energy to $222 From $182, Maintains Equalweight Rating

Valero Energy (VLO) has an average rating of overweight and mean price target of $254.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $240.41, Change: $+2.16, Percent Change: +0.91%

$VLO

Wire61d ago

Emergent BioSolutions Signs $34.5 Million Manufacturing Deal With Substipharm Biologics

Emergent BioSolutions (EBS) said Tuesday it has signed a $34.5 million deal with Substipharm Biologics to support drug substance manufacturing for the Japanese encephalitis vaccine at its Canton, Massachusetts, facility.As part of the agreement, Emergent said it will be the exclusive distributor of the vaccine to the US government, following potential US Food and Drug Administration regulatory clearances.Under a master manufacturing services agreement, Emergent said it will conduct operational and regulatory inspection readiness activities for the vaccine.Emergent shares were up 1.6% in Tuesday trading.Price: $8.16, Change: $+0.13, Percent Change: +1.62%

$EBS

Wire61d ago

Morgan Stanley Adjusts Price Target on Duke Energy to $141 From $142, Maintains Equalweight Rating

Duke Energy (DUK) has an average rating of overweight and mean price target of $139.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $127.27, Change: $+0.18, Percent Change: +0.14%

$DUK

Wire61d ago

United Community CFO Jefferson Harralson to Retire

United Community said Tuesday Chief Financial Officer Jefferson Harralson has elected to retire and will remain until the end of the year to ensure a smooth transition for his successor.The company said it has engaged Korn Ferry to assist in the search for his replacement.United Community Banks (UCB) is the financial holding company for United Community.Price: $33.93, Change: $+0.24, Percent Change: +0.71%

$UCB

Wire61d ago

Alaska Air Launches Nonstop Flight Service Between Seattle and Rome

Alaska Air (ALK) said Tuesday it launched its first nonstop daily seasonal flight service between Seattle and Rome, running from April 28 through Oct. 23.This new service will be operated on a 787-9 Dreamliner and enable connectivity between Hawai'i to and from Europe with a single stop via Seattle, according to a statement.The company also said it recently debuted its new global business class Suites experience, which applies to the new Rome flight service.Price: $40.17, Change: $-0.27, Percent Change: -0.66%

$ALK

Wire61d ago

Update: Market Chatter: Foreign Automakers Consider Pulling Cheapest Models From US Amid Trade Deal Uncertainty

(Updates with Honda's and Nissan's responses to requests for comment.)Foreign automakers have notified the Trump administration they could remove their cheapest car models from the US market if the US-Mexico-Canada Agreement is watered down or not renewed at all, The Wall Street Journal reported Tuesday, citing unnamed people familiar with the discussions.Toyota Motor (TM), Honda Motor (HMC), Nissan and Hyundai offer US consumers small, affordable cars, and though many of those are made in the US, they rely on parts from all three North American countries, the report said.Honda said it would continue selling the compact Civic in the US even without a trade deal, but that the economics of doing so would become more difficult without the certainty of free trade between North American nations, a Honda spokesperson toldvia email."Nissan is committed to providing affordable vehicles for American customers and is increasing US manufacturing to support that goal," a Nissan spokesperson toldvia email. "However, tariffs on entry-level vehicles are driving up costs and jeopardize affordability for consumers. We are actively engaging with leaders in the United States and Mexico to address this challenge."Toyota and Hyundai didn't immediately reply to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $193.23, Change: $+1.06, Percent Change: +0.55%

$HMC$TM

Showing 5341-5360 of 7117